Conventional therapy plus ACEIs favourable for CAD

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1538, 2006-01, pp. : 16-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

VEGF gene therapy promising in CAD

Inpharma, Vol. 1, Iss. 1374, 2003-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

ASTEROID widens scope for CAD therapy

Inpharma, Vol. 1, Iss. 1632, 2008-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Candesartan plus spironolactone induces favourable left ventricular (LV) reverse remodeling in patients with mild to moderate chronic heart failure

Inpharma, Vol. 1, Iss. 1601, 2007-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

QOL, depressive symptoms after hormone therapy in CAD

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 350, 2002-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Intensive statin therapy tops standard for CAD, ACS

Inpharma, Vol. 1, Iss. 1550, 2006-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite